iLENS: Interpretable LLM-Guided Mixture-of-Experts for Neuroimaging Survival Analysis
Introduction of iLENS, an interpretable Large Language Model (LLM) guided Mixture-of-Experts (MoE) framework designed for neuroimaging survival analysis in Alzheimer's Disease. The model utilizes LLMs to synthesize both structured neuroimaging measurements and unstructured clinical information to dynamically guide expert routing within the MoE architecture. iLENS achieves competitive predictive performance in AD conversion while offering transparent, biologically grounded rationales for its deci
Analysis
TL;DR
- Introduction of iLENS, an interpretable Large Language Model (LLM) guided Mixture-of-Experts (MoE) framework designed for neuroimaging survival analysis in Alzheimer's Disease.
- The model utilizes LLMs to synthesize both structured neuroimaging measurements and unstructured clinical information to dynamically guide expert routing within the MoE architecture.
- iLENS achieves competitive predictive performance in AD conversion while offering transparent, biologically grounded rationales for its decisions, addressing the interpretability gap in traditional survival models.
- The framework enables effective patient subtyping, providing clinicians with actionable insights into disease progression mechanisms through natural language reasoning capabilities.
Why It Matters
This research bridges the critical divide between high-performance machine learning models and clinical usability by introducing interpretability into survival analysis for neurodegenerative diseases. For AI practitioners and medical researchers, it demonstrates how LLMs can serve as intelligent routers in hybrid architectures, leveraging multimodal data to enhance both accuracy and transparency. This approach sets a new standard for clinical decision support systems where understanding the "why" behind a prediction is as important as the prediction itself.
Technical Details
- Architecture: Combines a Mixture-of-Experts (MoE) structure with an LLM-based gating mechanism, allowing for specialized processing of different patient data subsets.
- Multimodal Synthesis: The LLM component integrates structured neuroimaging metrics with unstructured clinical notes or reports to create a comprehensive context for routing decisions.
- Interpretability Mechanism: Generates explicit, biologically plausible explanations for why specific experts were activated, linking model decisions to known pathological markers of Alzheimer's.
- Application Domain: Specifically targeted at prodromal Alzheimer's Disease, focusing on survival prediction (time-to-event analysis) and patient subtyping rather than simple classification.
Industry Insight
- Hybrid Models for Clinical AI: The success of LLM-guided MoE suggests a shift toward hybrid architectures where generative models handle semantic reasoning and routing, while specialized neural networks handle numerical or imaging data.
- Regulatory and Trust Implications: Providing biologically grounded rationales is essential for regulatory approval and clinician trust; frameworks like iLENS offer a blueprint for building "explainable-by-design" medical AI.
- Data Integration Strategy: Effective synthesis of structured and unstructured data is a key bottleneck in medical AI; this work highlights the value of LLMs in harmonizing diverse data types for downstream predictive tasks.
Disclaimer: The above content is generated by AI and is for reference only.